- Home
- SFM vs ROIV Comparison
SFM vs ROIV Comparison
Compare SFM & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFM
- ROIV
- Stock Information
- Founded
- SFM 2002
- ROIV 2014
- Country
- SFM United States
- ROIV United Kingdom
- Employees
- SFM N/A
- ROIV N/A
- Industry
- SFM Food Chains
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- SFM Consumer Staples
- ROIV Health Care
- Exchange
- SFM Nasdaq
- ROIV Nasdaq
- Market Cap
- SFM 14.4B
- ROIV 8.6B
- IPO Year
- SFM 2013
- ROIV N/A
- Fundamental
- Price
- SFM $135.98
- ROIV $14.08
- Analyst Decision
- SFM Buy
- ROIV Strong Buy
- Analyst Count
- SFM 15
- ROIV 4
- Target Price
- SFM $168.20
- ROIV $15.50
- AVG Volume (30 Days)
- SFM 1.6M
- ROIV 6.6M
- Earning Date
- SFM 10-29-2025
- ROIV 11-11-2025
- Dividend Yield
- SFM N/A
- ROIV N/A
- EPS Growth
- SFM 52.36
- ROIV N/A
- EPS
- SFM 4.84
- ROIV N/A
- Revenue
- SFM $8,399,001,000.00
- ROIV $23,233,000.00
- Revenue This Year
- SFM $16.57
- ROIV N/A
- Revenue Next Year
- SFM $11.38
- ROIV $281.14
- P/E Ratio
- SFM $28.12
- ROIV N/A
- Revenue Growth
- SFM 16.83
- ROIV N/A
- 52 Week Low
- SFM $100.59
- ROIV $8.73
- 52 Week High
- SFM $182.00
- ROIV $14.48
- Technical
- Relative Strength Index (RSI)
- SFM 34.81
- ROIV 76.40
- Support Level
- SFM $132.72
- ROIV $11.85
- Resistance Level
- SFM $141.24
- ROIV $14.48
- Average True Range (ATR)
- SFM 3.11
- ROIV 0.42
- MACD
- SFM -0.08
- ROIV 0.21
- Stochastic Oscillator
- SFM 22.58
- ROIV 86.26
About SFM Sprouts Farmers Market Inc.
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.